Revised definitions of invasive fungal disease from the European Organization for research and treatment of cancer/invasive fungal infections cooperative group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) consensus group

ABSTRACT : Background. Invasive fungal diseases are important causes of morbidity and mortality. Clarity and uniformity in defining these infections are important factors in improving the quality of clinical studies. A standard set of definitions strengthens the consistency and reproducibility of su...

Full description

Autores:
De Pauw, Ben
Walsh, Thomas J
Donnelly, J Peter
Stevens, David A
Edwards, John E
Calandra, Thierry
Pappas, Peter G
Maertens, Johan
Lortholary, Olivier
Kauffman, Carol A
Denning, David W
Patterson, Thomas F
Maschmeyer, Georg
Bille, Jacques
Dismukes, William E
Herbrecht, Raoul
Hope, William W
Kibbler, Christopher C
Kullberg, Bart Jan
Marr, Kieren A
Munoz, Patricia
Odds, Frank C
Perfect, John R
Restrepo Moreno, Ángela
Ruhnke, Markus
Segal, Brahm H
Sobel, Jack D
Sorrell, Tania C
Viscoli, Claudio
Wingard, John R
Zaoutis, Theoklis
Bennett, John E
Tipo de recurso:
Article of investigation
Fecha de publicación:
2008
Institución:
Universidad de Antioquia
Repositorio:
Repositorio UdeA
Idioma:
eng
OAI Identifier:
oai:bibliotecadigital.udea.edu.co:10495/24087
Acceso en línea:
http://hdl.handle.net/10495/24087
Palabra clave:
Micosis - clasificación
Mycoses - classification
Micosis - diagnóstico
Mycoses - diagnosis
Terminología como Asunto
Terminology as Topic
Rights
openAccess
License
http://creativecommons.org/licenses/by-nc-nd/2.5/co/
id UDEA2_53599fa77a93b8d400009ebe937f4360
oai_identifier_str oai:bibliotecadigital.udea.edu.co:10495/24087
network_acronym_str UDEA2
network_name_str Repositorio UdeA
repository_id_str
dc.title.spa.fl_str_mv Revised definitions of invasive fungal disease from the European Organization for research and treatment of cancer/invasive fungal infections cooperative group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) consensus group
title Revised definitions of invasive fungal disease from the European Organization for research and treatment of cancer/invasive fungal infections cooperative group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) consensus group
spellingShingle Revised definitions of invasive fungal disease from the European Organization for research and treatment of cancer/invasive fungal infections cooperative group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) consensus group
Micosis - clasificación
Mycoses - classification
Micosis - diagnóstico
Mycoses - diagnosis
Terminología como Asunto
Terminology as Topic
title_short Revised definitions of invasive fungal disease from the European Organization for research and treatment of cancer/invasive fungal infections cooperative group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) consensus group
title_full Revised definitions of invasive fungal disease from the European Organization for research and treatment of cancer/invasive fungal infections cooperative group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) consensus group
title_fullStr Revised definitions of invasive fungal disease from the European Organization for research and treatment of cancer/invasive fungal infections cooperative group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) consensus group
title_full_unstemmed Revised definitions of invasive fungal disease from the European Organization for research and treatment of cancer/invasive fungal infections cooperative group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) consensus group
title_sort Revised definitions of invasive fungal disease from the European Organization for research and treatment of cancer/invasive fungal infections cooperative group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) consensus group
dc.creator.fl_str_mv De Pauw, Ben
Walsh, Thomas J
Donnelly, J Peter
Stevens, David A
Edwards, John E
Calandra, Thierry
Pappas, Peter G
Maertens, Johan
Lortholary, Olivier
Kauffman, Carol A
Denning, David W
Patterson, Thomas F
Maschmeyer, Georg
Bille, Jacques
Dismukes, William E
Herbrecht, Raoul
Hope, William W
Kibbler, Christopher C
Kullberg, Bart Jan
Marr, Kieren A
Munoz, Patricia
Odds, Frank C
Perfect, John R
Restrepo Moreno, Ángela
Ruhnke, Markus
Segal, Brahm H
Sobel, Jack D
Sorrell, Tania C
Viscoli, Claudio
Wingard, John R
Zaoutis, Theoklis
Bennett, John E
dc.contributor.author.none.fl_str_mv De Pauw, Ben
Walsh, Thomas J
Donnelly, J Peter
Stevens, David A
Edwards, John E
Calandra, Thierry
Pappas, Peter G
Maertens, Johan
Lortholary, Olivier
Kauffman, Carol A
Denning, David W
Patterson, Thomas F
Maschmeyer, Georg
Bille, Jacques
Dismukes, William E
Herbrecht, Raoul
Hope, William W
Kibbler, Christopher C
Kullberg, Bart Jan
Marr, Kieren A
Munoz, Patricia
Odds, Frank C
Perfect, John R
Restrepo Moreno, Ángela
Ruhnke, Markus
Segal, Brahm H
Sobel, Jack D
Sorrell, Tania C
Viscoli, Claudio
Wingard, John R
Zaoutis, Theoklis
Bennett, John E
dc.subject.decs.none.fl_str_mv Micosis - clasificación
Mycoses - classification
Micosis - diagnóstico
Mycoses - diagnosis
Terminología como Asunto
Terminology as Topic
topic Micosis - clasificación
Mycoses - classification
Micosis - diagnóstico
Mycoses - diagnosis
Terminología como Asunto
Terminology as Topic
description ABSTRACT : Background. Invasive fungal diseases are important causes of morbidity and mortality. Clarity and uniformity in defining these infections are important factors in improving the quality of clinical studies. A standard set of definitions strengthens the consistency and reproducibility of such studies. Methods. After the introduction of the original European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group definitions, advances in diagnostic technology and the recognition of areas in need of improvement led to a revision of this document. The revision process started with a meeting of participants in 2003, to decide on the process and to draft the proposal. This was followed by several rounds of consultation until a final draft was approved in 2005. This was made available for 6 months to allow public comment, and then the manuscript was prepared and approved. Results. The revised definitions retain the original classifications of “proven,” “probable,” and “possible” invasive fungal disease, but the definition of “probable” has been expanded, whereas the scope of the category “possible” has been diminished. The category of proven invasive fungal disease can apply to any patient, regardless of whether the patient is immunocompromised, whereas the probable and possible categories are proposed for immunocompromised patients only. Conclusions. These revised definitions of invasive fungal disease are intended to advance clinical and epidemiological research and may serve as a useful model for defining other infections in high-risk patients.
publishDate 2008
dc.date.issued.none.fl_str_mv 2008
dc.date.accessioned.none.fl_str_mv 2021-11-14T12:55:36Z
dc.date.available.none.fl_str_mv 2021-11-14T12:55:36Z
dc.type.spa.fl_str_mv info:eu-repo/semantics/article
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.hasversion.spa.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.coar.spa.fl_str_mv http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.redcol.spa.fl_str_mv https://purl.org/redcol/resource_type/ART
dc.type.local.spa.fl_str_mv Artículo de investigación
format http://purl.org/coar/resource_type/c_2df8fbb1
status_str publishedVersion
dc.identifier.issn.none.fl_str_mv 1058-4838
dc.identifier.uri.none.fl_str_mv http://hdl.handle.net/10495/24087
dc.identifier.doi.none.fl_str_mv 10.1086/588660
dc.identifier.eissn.none.fl_str_mv 1537-6591
identifier_str_mv 1058-4838
10.1086/588660
1537-6591
url http://hdl.handle.net/10495/24087
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.ispartofjournalabbrev.spa.fl_str_mv Clin. Infect. Dis.
dc.rights.spa.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.uri.*.fl_str_mv http://creativecommons.org/licenses/by-nc-nd/2.5/co/
dc.rights.accessrights.spa.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.creativecommons.spa.fl_str_mv https://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
rights_invalid_str_mv http://creativecommons.org/licenses/by-nc-nd/2.5/co/
http://purl.org/coar/access_right/c_abf2
https://creativecommons.org/licenses/by-nc-nd/4.0/
dc.format.extent.spa.fl_str_mv 9
dc.format.mimetype.spa.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv University of Chicago Press
dc.publisher.group.spa.fl_str_mv Micología Médica y Experimental
dc.publisher.place.spa.fl_str_mv Chicago, Estados Unidos
institution Universidad de Antioquia
bitstream.url.fl_str_mv http://bibliotecadigital.udea.edu.co/bitstream/10495/24087/1/RestrepoAngela_2008_DefinitionsInvasiveCancer.pdf
http://bibliotecadigital.udea.edu.co/bitstream/10495/24087/2/license_rdf
http://bibliotecadigital.udea.edu.co/bitstream/10495/24087/3/license.txt
bitstream.checksum.fl_str_mv 38c7ab71c331ef05f4dd562f4dfef734
b88b088d9957e670ce3b3fbe2eedbc13
8a4605be74aa9ea9d79846c1fba20a33
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositorio Institucional Universidad de Antioquia
repository.mail.fl_str_mv andres.perez@udea.edu.co
_version_ 1805390217152036864
spelling De Pauw, BenWalsh, Thomas JDonnelly, J PeterStevens, David AEdwards, John ECalandra, ThierryPappas, Peter GMaertens, JohanLortholary, OlivierKauffman, Carol ADenning, David WPatterson, Thomas FMaschmeyer, GeorgBille, JacquesDismukes, William EHerbrecht, RaoulHope, William WKibbler, Christopher CKullberg, Bart JanMarr, Kieren AMunoz, PatriciaOdds, Frank CPerfect, John RRestrepo Moreno, ÁngelaRuhnke, MarkusSegal, Brahm HSobel, Jack DSorrell, Tania CViscoli, ClaudioWingard, John RZaoutis, TheoklisBennett, John E2021-11-14T12:55:36Z2021-11-14T12:55:36Z20081058-4838http://hdl.handle.net/10495/2408710.1086/5886601537-6591ABSTRACT : Background. Invasive fungal diseases are important causes of morbidity and mortality. Clarity and uniformity in defining these infections are important factors in improving the quality of clinical studies. A standard set of definitions strengthens the consistency and reproducibility of such studies. Methods. After the introduction of the original European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group definitions, advances in diagnostic technology and the recognition of areas in need of improvement led to a revision of this document. The revision process started with a meeting of participants in 2003, to decide on the process and to draft the proposal. This was followed by several rounds of consultation until a final draft was approved in 2005. This was made available for 6 months to allow public comment, and then the manuscript was prepared and approved. Results. The revised definitions retain the original classifications of “proven,” “probable,” and “possible” invasive fungal disease, but the definition of “probable” has been expanded, whereas the scope of the category “possible” has been diminished. The category of proven invasive fungal disease can apply to any patient, regardless of whether the patient is immunocompromised, whereas the probable and possible categories are proposed for immunocompromised patients only. Conclusions. These revised definitions of invasive fungal disease are intended to advance clinical and epidemiological research and may serve as a useful model for defining other infections in high-risk patients.COL00137099application/pdfengUniversity of Chicago PressMicología Médica y ExperimentalChicago, Estados Unidosinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://purl.org/coar/resource_type/c_2df8fbb1https://purl.org/redcol/resource_type/ARTArtículo de investigaciónhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/openAccesshttp://creativecommons.org/licenses/by-nc-nd/2.5/co/http://purl.org/coar/access_right/c_abf2https://creativecommons.org/licenses/by-nc-nd/4.0/Revised definitions of invasive fungal disease from the European Organization for research and treatment of cancer/invasive fungal infections cooperative group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) consensus groupMicosis - clasificaciónMycoses - classificationMicosis - diagnósticoMycoses - diagnosisTerminología como AsuntoTerminology as TopicClin. Infect. Dis.Clinical Infectious Diseases181318214612ORIGINALRestrepoAngela_2008_DefinitionsInvasiveCancer.pdfRestrepoAngela_2008_DefinitionsInvasiveCancer.pdfArtículo de investigaciónapplication/pdf308990http://bibliotecadigital.udea.edu.co/bitstream/10495/24087/1/RestrepoAngela_2008_DefinitionsInvasiveCancer.pdf38c7ab71c331ef05f4dd562f4dfef734MD51CC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8823http://bibliotecadigital.udea.edu.co/bitstream/10495/24087/2/license_rdfb88b088d9957e670ce3b3fbe2eedbc13MD52LICENSElicense.txtlicense.txttext/plain; charset=utf-81748http://bibliotecadigital.udea.edu.co/bitstream/10495/24087/3/license.txt8a4605be74aa9ea9d79846c1fba20a33MD5310495/24087oai:bibliotecadigital.udea.edu.co:10495/240872022-04-22 10:20:54.031Repositorio Institucional Universidad de Antioquiaandres.perez@udea.edu.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